We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$204M
2
TSM icon
TSMC
TSM
+$94.9M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$58M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$23M
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$17.9M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$52.8M
2
AAPL icon
Apple
AAPL
+$32.5M
3
MSFT icon
Microsoft
MSFT
+$16.2M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$14.5M
5
DIS icon
Walt Disney
DIS
+$14.2M

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VWE
2976
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
$31K ﹤0.01%
28,617
+25,567
+838% +$52.9K
NGMS
2977
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
$31K ﹤0.01%
2,048
-4,344
-68% -$61.1K
DMK
2978
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$31K ﹤0.01%
3,840
+148
+4% +$1.97K
KVSC
2979
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
$31K ﹤0.01%
3,058
+2,419
+379% +$24.4K
ABUS icon
2980
Arbutus Biopharma
ABUS
$908M
$30K ﹤0.01%
9,792
-5,026
-34% -$14.2K
ADT icon
2981
ADT
ADT
$5.48B
$30K ﹤0.01%
4,060
+3,186
+365% +$26K
ASTS icon
2982
AST SpaceMobile
ASTS
$20.9B
$30K ﹤0.01%
5,890
+5,585
+1,831% +$32.2K
BCAB icon
2983
BioAtla
BCAB
$5.43M
$30K ﹤0.01%
226
+94
+71% +$16.9K
BNS icon
2984
Scotiabank
BNS
$111B
$30K ﹤0.01%
593
-7,026
-92% -$360K
CRMD icon
2985
CorMedix
CRMD
$605M
$30K ﹤0.01%
7,314
-10
-0.1% -$41
DHIL
2986
DELISTED
Diamond Hill
DHIL
$30K ﹤0.01%
184
+139
+309% +$24.7K
DRRX
2987
DELISTED
DURECT Corp
DRRX
$30K ﹤0.01%
6,635
+3,604
+119% +$19.6K
ECVT icon
2988
Ecovyst
ECVT
$1.13B
$30K ﹤0.01%
2,800
-206
-7% -$2.13K
EUM icon
2989
ProShares Trust Short MSCI Emerging Markets
EUM
$9.26M
$30K ﹤0.01%
1,025
-132
-11% -$3.86K
EWS icon
2990
iShares MSCI Singapore ETF
EWS
$1.16B
$30K ﹤0.01%
1,497
-87
-5% -$1.7K
FBK icon
2991
FB Financial Corp
FBK
$3.1B
$30K ﹤0.01%
979
+833
+571% +$29.8K
CBIO
2992
Crescent Biopharma
CBIO
$624M
$30K ﹤0.01%
+244
New +$54.9K
GRBK icon
2993
Green Brick Partners
GRBK
$3.03B
$30K ﹤0.01%
854
+518
+154% +$16K
GTN icon
2994
Gray Television
GTN
$529M
$30K ﹤0.01%
3,434
+2,903
+547% +$32.4K
IVT icon
2995
InvenTrust Properties
IVT
$2.63B
$30K ﹤0.01%
1,277
-102
-7% -$2.41K
MILN
2996
Global X Millennial Consumer ETF
MILN
$103M
$30K ﹤0.01%
999
-483
-33% -$14K
MLNK
2997
DELISTED
MeridianLink
MLNK
$30K ﹤0.01%
1,737
-2,336
-57% -$37.6K
NIC icon
2998
Nicolet Bankshares
NIC
$3.76B
$30K ﹤0.01%
473
-194
-29% -$14K
OCFT
2999
DELISTED
OneConnect Financial Technology
OCFT
$30K ﹤0.01%
5,592
-2,595
-32% -$17.5K
OII icon
3000
Oceaneering
OII
$5.24B
$30K ﹤0.01%
1,727
+238
+16% +$4.59K
118 119
120
121 122

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.